Тёмный
No video :(

Hydroxyurea for Sickle Cell Anemia 

NEJM Group
Подписаться 156 тыс.
Просмотров 9 тыс.
50% 1

Sickle cell anemia is associated with acute and chronic complications that lead to poor quality of life and early death. Hydroxyurea is an effective treatment, but few studies have been conducted in sub-Saharan Africa, where the burden is greatest. Full study: nej.md/2E2SroN
Browse the Quick Take video archive: nej.md/quick-take

Опубликовано:

 

29 авг 2024

Поделиться:

Ссылка:

Скачать:

Готовим ссылку...

Добавить в:

Мой плейлист
Посмотреть позже
Комментарии : 8   
@fit2day239
@fit2day239 5 лет назад
Wow!!! I just briefly read part of the research yesterday on the NEJM website. Thank you tremendously for this video. I will like it as well as share it with my colleagues.
@TPPerspectiv
@TPPerspectiv 5 лет назад
We need to have standardized practice protocols for management of sickle cell anemia in sub saharan African countries like Uganda. Currently there's none. Health workers still don't know when to use this wonderful drug.
@Rene-uz3eb
@Rene-uz3eb 8 месяцев назад
I get the feeling the industry doesn't like it when something cheap works too well. The improvement was shown here on log tables, in fact improvement was an order of magnitude. In reality, results would probably be even better given it's unlikely there was proper adherence (take daily pills for a year, by kids, with no way to see if it makes a difference because the effect is months out)
@brainman709
@brainman709 4 года назад
Very useful!
Далее
Sickle Cell Disease “part 4”: Diagnosis& treatment
10:01
Hydroxyurea in Sickle Cell Disease
8:43
Просмотров 5 тыс.
娜美这是在浪费食物 #路飞#海贼王
00:20
Hemoglobin and Hemoglobinopathies
10:07
Просмотров 135 тыс.
Can CRISPR cure Sickle-cell Disease?
10:42
Просмотров 80 тыс.
Sickle Cell Disease
5:29
Просмотров 883 тыс.
Case Discussion || Sickle Cell Crisis
12:16
Просмотров 2,7 тыс.
Sickle Cell Patients and Hydroxyurea Treatment
5:54
Просмотров 24 тыс.
Sickle Cell Disease “Part 1” Intro
11:01
Просмотров 184 тыс.